Meeting
2016 ASCO Annual Meeting
PSMA ADC for progressive glioblastoma: Phase II Brown University Oncology Research Group Study.
Authors
Heinrich Elinzano
Rhode Island Hospital, Providence, RI
Heinrich Elinzano , Nicholas Hebda , Denise Luppe , Wendy Turchetti , Kayla Rosati , William M. Sikov , Howard Safran
Disclaimer
This material on this page is ©2024 American Society of Clinical Oncology, all rights reserved. Licensing available upon request. For more information, please contact licensing@asco.org
Poster Details
Session Type
Poster Session
Session Title
Central Nervous System Tumors
Track
Central Nervous System Tumors
Sub Track
Central Nervous System Tumors
Clinical Trial Registration Number
NCT01856933
Citation
J Clin Oncol 34, 2016 (suppl; abstr 2065)
DOI
10.1200/JCO.2016.34.15_suppl.2065
Abstract #
2065
Poster Bd #
252
Abstract Disclosures
Similar Posters
Poster
2020 ASCO Virtual Scientific Program
Accelerator-based BNCT in rescue treatment of patients with recurrent GBM: A multicenter phase II study.
First Author: Shin-Ichi Miyatake
Poster
2019 ASCO Annual Meeting
A TITE-CRM phase I/II study of disulfiram and copper with concurrent radiation therapy and temozolomide for newly diagnosed glioblastoma.
First Author: Jiayi Huang
Poster
2017 ASCO Annual Meeting
Phase II trial of bevacizumab and temozolomide for upfront treatment of elderly patients with newly diagnosed glioblastoma.
First Author: Phioanh Leia Nghiemphu
Poster
2017 ASCO Annual Meeting
Bevacizumab plus hypofractionated radiotherapy versus radiotherapy alone in elderly patients with glioblastoma: Efficacy and imaging analyses of the ARTE trial.
First Author: Hans-Georg Wirsching